Gavi, the Vaccine Alliance was founded to ensure a secure supply of vaccines at affordable prices to developing countries. Since its inception, private sector partnerships, through the mobilisation of resources or the leveraging of expertise and innovation, have been integral to Gavi's success.
Partnering with Gavi creates an opportunity for private sector partners to join a global alliance. Together, we can save lives, create sustainable socio-economic benefits and take a leading role in global development.
Gavi has already protected an entire generation of children and is now working to protect the next by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. With the support of it sprivate sector partners, through innovative financing and the latest technology – from drones to biometrics – it will continue to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency.
Supporting Gavi CORE immunisation programmes increases equitable and sustainable use of vaccines, transforming the lives of individuals, helping to boost the economies of lower-income countries and making the world safer for everyone. For more information on Gavi’s priorities see here.
COVAX is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both high-income and lower-income countries. Gavi leads on procurement and delivery at scale for COVAX: designing and managing the COVAX Facility and the Gavi COVAX Advance Market Commitment to ensure equitable access to a vaccine – wherever they are, and whatever their income level.
Funding Gavi COVAX AMC from the private sector means more doses for lower-income countries and more flexibility to help us prepare for the future – meaning a faster end to the acute phase of this pandemic for the whole world and getting on track for global economic recovery.
Enter fast-growing market
Gavi's global reach opens up new growth opportunities. We have supported immunisation in more than 70 countries – many of which are emerging and developing markets.
Partner with global leaders
The Alliance brings together leaders from the highest levels, including key players in global health and government as well as in business, philanthropy and development.
Support global development
Gavi is at the forefront of efforts to end preventable child deaths – a key objective of the United Nations' Sustainable Development Goals. Supporting Gavi can advance your ESG objectives.
Connect with entrepreneurs
Gavi helps to accelerate the introduction of a range of new technologies in developing countries. This gives private sector partners access to a network of other innovators in development.
Make an immediate and lasting impact
Investing in immunisation leaves a long-lasting legacy. Immunised children are protected for life. They are more likely to stay in school and build a productive future, both for themselves and their communities.
HOW DO WE COLLABORATE WITH THE PRIVATE SECTOR?
By establishing strategic partnerships with leaders in business and industry we are able to use the private sector's financial resources, operational expertise, thought-leadership and innovation to support our goals on vaccine coverage and equity.
EXPERTISE BASED PARTNERSHIPS
We work with private sector partners to develop long-term relationships and create sustainable impact. Corporations can partner with Gavi by sharing industry expertise, technology, and know how to overcome the stubborn bottlenecks that prevent vaccines being available for every child.
Increasing demand for new vaccines is placing ever greater pressure on immunisation delivery systems in developing countries. We are continuously looking to foster innovation, in close collaboration with private businesses and the technology industry, to address these issues.
Launched in 2011, the Matching Fund doubles multiplies private sector partners' impact by doubling their investment. By encouraging business to invest in immunisation, the Gavi Matching Fund has been a critical component in the expansion of our private sector engagement.
What does it take to get a vaccine made in India to a rural clinic in Malawi, or a diagnostic kit assembled in China to a town in Senegal? Miles of travel, hours of storage and lots of planning. But it’s an imperfect process, thanks to an absence…
Aviation links the world. The sector has been at the heart of the COVID pandemic, from adapting to travel restrictions to transporting vaccines and vital health equipment. Find out how a coalition of companies has been working together to support…
The pandemic made the challenge of training health workers in lower-income countries even harder. To counter the huge impact COVID-19 is having on health systems worldwide, a collaboration between Gavi and The Rockefeller Foundation is improving…
Covering 70% of pharmaceutical goods moved around the world, IFPW is a global group of wholesalers and distributors. Find out how they have been working with Gavi to improve soft skills in the world’s immunization and pharmaceutical supply chains…
‘Soft skills’, from motivating a team to tapping into networks, provide the vital oil that keeps supply chains moving smoothly. A programme called STEP is bringing together businesses and the public sector to help healthcare managers in the…
Mastercard, a long-standing partner of Gavi, recently committed US$ 28 million to the Gavi COVAX AMC, to ensure vaccines are accessible to those that needed them the most, no matter where they live. Vaccines Work spoke to Michael Froman to learn…
Ghana is not only the first country to receive a shipment of COVAX vaccines, but it will be the first to broaden its reach by delivering them by drone. The new partnership with Zipline and UPS Foundation will see 2.5 million doses delivered this…
Zipline is a California-based automated logistics company that uses autonomous drones to make on-demand, emergency deliveries of high priority products, including emergency and routine vaccines and other health products.